Wu M. and Huang Sh., Magnetic nanoparticles in cancer diagnosis, drug delivery and treatment, Molecular and Clinical Oncology, 7, 738–746, 2017.
2- Abou-Jawde R., Choueiri T., Alemany C. and Mekhail T., An overview of targeted treatments in cancer, Clinical therapeutics, Clin Ther., 25, 2121-2137, 2003.
3- Longley D., Harkin P., and Johnston P., 5-fluorouracil: mechanisms of action and clinical strategies, Nature reviews Cancer, 3, 330, 2003.
4- Dilnawaz F., Singh A., Mohanty C., Sahoo K., Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy, Biomaterials, 31, 3694–3706, 2010.
5- Felt F., Mayer JM., Plazonet B., Buri P., Gurny R., Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention, International Journal of Pharmaceutics, 180, 185-93, 1999.
6- Ericsson B., Eriksson P., Lofroth J., Engstrom S., Cubic phases as delivery systems for peptide drugs, ACS Symposium Series, 469, 251-265, 1991.
7- Lübbe A., Alexiou C., and Bergemann C., Clinical applications of magnetic drug targeting, Journal of Surgical Research, 95, 200-206, 2001.
8- Jun Jie W., Wu Zeng Z., Zhong Xiao R., Xie T., Lin Zhou G., Zhan X., and Ling Wang Sh., Recent advances of chitosan nanoparticles as drug carriers, International journal of nanomedicine, 6, 765, 2011.
9- Kumar K., Shah M., Ketkar A., Mahadik, and Paradkar A., Effect of drug solubility and different excipients on floating behaviour and release from glyceryl monooleate matrices, International journal of pharmaceutics, 272, 151-160, 2004.
10- Bagheri G., Dorkoosh F., Vasheghani-Farahani E., Ardjmand M., Formulation and Optimization of Controlled Release of Olanzapine by Glycerol Monooleate, Medical journal of Tabriz university, 36, 51-59, 2015.
11- Jafari M, Assadpoor E, Bhandari B and He Y, Nano-particle encapsulation of fish oil by spray drying, Journal of Food Research International, 41, 172–183, 2008.
12- Wulandari O. et al., Preparation and Characterization of Chitosan-coated Fe3O4 Nanoparticles using Ex-Situ Co-Precipitation Method and Tripolyphosphate/Sulphate as Dual Crosslinkers, Conf. Ser.: Material Science Engineering, 2018.
13- Zarzycki R, Modrzejewska Z, Nawrotek K, Drug release from hydrogel matrices, Chemical Engineering, 17, 117-36, 2010.
14- Jianjun Z., Fu M., Zhang M., Xu L., and Gao Y., Synthesis of oxidized glycerol monooleate-chitosan polymer and its hydrogel formation for sustained release of trimetazidine hydrochloride, International journal of pharmaceutics, 465, 32-41, 2014.
15- Patel DM., Harshvadan Jani R., Patel CN., Design and evaluation of colon targeted modified pulsincap delivery of 5-fluorouracil according to circadian rhythm, International Journal of Pharmaceutical Investigation 1, 172-81, 2011.
16- Glavcheva-Laleva Z., Varadinova V., Kerekov St., Pavlov D., Glavchev Iv., Application of waste glycerol from biodiesel productionfor obtaining of modifiers for reduced friction of different motor oils, Bulgarian Chemical Communications, 47, 118-123, 2015.
17- Meyer D., Shin G., Kong M., Dewhirst and Chilkoti A., Drug targeting using thermally responsive polymers and local hyperthermia, Journal of controlled release, 74, 213-224, 2001.
18- Ericsson B., Eriksson P., Lofroth J., Engstrom S., Cubic phases as delivery systems for peptide drugs, ACS Symposium Series, 5, 251-265, 1991.
19- Trickler W., Nagvekar A., and Dash A., The in vitro sub-cellular localization and in vivo efficacy of novel chitosan/GMO nanostructures containing paclitaxel, Pharmaceutical research, 26, 1963-1973, 2009.
20- Bagheri G., Dorkoosh F., Vasheghani-Farahani E., Ardjmand M., Design of controlled release of Olanzapine by using Glycerol Monooleate in Sol-gel Systems, New Cellular and Molecular Biotechnology Journal, 5, 81-88, 2015.
21- Loebinger MR., Kyrtatos PG., Turmaine M., Price AN., Pankhurst Q., Lythgoe MF., Janes SM., Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles, Cancer Research, 69, 8862-7, 2009.
